Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

CO: Grower receives QA certirfication for cultivation and processing operations

PharmaCielo Ltd. has received the ISO 9001:2015 certification for its cultivation and extraction operations.

"The ISO 9001 certification, awarded to PharmaCielo, covers the production of vegetable materials for the propagation, flowering and production of both psychoactive (THC) and non-psychoactive (CBD) cannabis. It was achieved following a rigorous audit process conducted at the Company’s Colombian facilities by inspection and certification company SGS", the company explains

“The recognition provided is the result of the quality and high operating standards our Colombian team brings to the nursery,” says Federico Cock-Correa, president of PharmaCielo Colombia Holdings SAS. 

ISO 9001 is the international standard that specifies requirements for a quality management system (QMS). Organizations use the standard to demonstrate their ability to consistently provide products and services that meet customer and regulatory requirements.

“As the global medicinal cannabis market continues to evolve, and additional markets open for the use of medical cannabis and derived products, companies that can assure customers, patients, healthcare providers and regulators of the quality and consistency of the product will be the top players,” adds Dr. Delon Human, PharmaCielo’s Global Head, Health and Innovation.

"PharmaCielo’s processing facilities have been designed and operate to fulfill GMP (Good Manufacturing Processes) standards, ensuring that products are consistently high in quality and guarantee total traceability. Receipt of GMP certification for the Research and Technology Centre (RTC), as the centre of medicinal oil extraction processes, is expected in coming months", the company concludes. 

For more information:
PharmaCielo
investors@pharmacielo.com  
pharmacielo.com 

Publication date: